Ciltacabtagene autoleucel for treating relapsed and lenalidomide-refractory multiple myeloma after 1 to 3 therapies [ID4012]

  • In development
  • GID-TA10905
  • Expected publication date: TBC

Documents

Documents created during the development process.

Notes